Hikma Pharmaceuticals PLC (LON:HIK – Get Free Report)’s stock price passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 1,928.90 ($23.47) and traded as high as GBX 2,102 ($25.57). Hikma Pharmaceuticals shares last traded at GBX 2,091.92 ($25.45), with a volume of 345,375 shares traded.
Hikma Pharmaceuticals Price Performance
The company has a debt-to-equity ratio of 55.48, a current ratio of 1.66 and a quick ratio of 1.27. The business has a fifty day moving average of GBX 1,949.17 and a 200 day moving average of GBX 1,928.90. The stock has a market cap of £4.64 billion, a PE ratio of 3,218.34, a P/E/G ratio of 2.38 and a beta of 0.41.
About Hikma Pharmaceuticals
At Hikma we help put better health within reach, every day. By creating high-quality medicines and making them accessible to the people who need them, we help to shape a healthier world that enriches all our communities. We help deliver this by living our culture, delivering our strategy, and acting responsibly.
Featured Stories
- Five stocks we like better than Hikma Pharmaceuticals
- ETF Screener: Uses and Step-by-Step Guide
- AI Demand Sparks Opportunities for These 3 Nuclear Energy Leaders
- How to Calculate Retirement Income: MarketBeat’s Calculator
- TSMC: Long-Term Outlook Still Strong as Geopolitical Risk Rises
- How to Invest in Biotech Stocks
- Uber’s NVIDIA Deal and Buybacks Signal Major Upside
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
